Cost-effectiveness of inhaled fluticasone propionate in the treatment of patients with chronic obstructive pulmonary disease (COPD)

被引：0
|
作者：
Hurrell, C [1 ]
Price, MJ [1 ]
Hollingworth, KE [1 ]
Thwaites, RMA [1 ]
机构：
[1] Glaxo Wellcome, Greenford, Middx, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A797 / A797
页数：1
相关论文
共 50 条
  • [21] Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
    Paggiaro, PL
    Dahle, R
    Bakran, I
    Frith, L
    Hollingworth, K
    Efthimiou, J
    [J]. LANCET, 1998, 351 (9105): : 773 - 780
  • [22] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    Calverley, Peter M. A.
    Anderson, Julie A.
    Celli, Bartolome
    Ferguson, Gary T.
    Jenkins, Christine
    Jones, Paul W.
    Yates, Julie C.
    Vestbo, Jorgen
    Calverley, P. M. A.
    Anderson, J. A.
    Celli, B.
    Ferguson, G. T.
    Jenkins, C.
    Jones, P. W.
    Knobil, K.
    Yates, J. C.
    Vestbo, J.
    Cherniack, R.
    Similowski, T.
    Cleland, J.
    Whitehead, A.
    Wise, R.
    McGarvey, L.
    John, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08): : 775 - 789
  • [23] Evaluating the cost-effectiveness of tiotropium in the treatment of moderate chronic obstructive pulmonary disease
    Naik, S.
    Kamal, K. M.
    Keys, P.
    Mattei, T.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A178 - A179
  • [24] COST-EFFECTIVENESS OF INDACATEROL ON PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AT THE PUBLIC MEXICAN HEALTH CARE SYSTEM
    Reyes-lopez, A.
    Lemus-Carmona, E. A.
    Orozco, E.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A55 - A55
  • [25] Cost-effectiveness of erdosteine in the treatment of acute exacerbations of chronic obstructive pulmonary disease
    Haughney, J.
    Grishchenko, M.
    Dakin, H. A.
    Ballabio, M.
    Caputo, G.
    [J]. THORAX, 2007, 62 : A47 - A47
  • [26] COST-EFFECTIVENESS OF INDACATEROL/GLYCOPYRRONIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN BRAZIL
    Tozato, C.
    Suzuki, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S411 - S411
  • [27] Cost-Effectiveness Of Combination Fluticasone Propionate/Salmeterol 250/50 Mcg Versus Salmeterol In Chronic Obstructive Pulmonary Disease (COPD): Data From Two Well Controlled Exacerbation Trials
    Dalal, A. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [28] Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD)
    Bandurska, Ewa
    Damps-Konstanska, Iwona
    Popowski, Piotr
    Jedrzejczyk, Tadeusz
    Janowiak, Piotr
    Swietnicka, Katarzyna
    Zarzeczna-Baran, Marzena
    Jassem, Ewa
    [J]. MEDICAL SCIENCE MONITOR, 2019, 25 : 2879 - 2885
  • [29] A NOVEL MODELLING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) INTERVENTIONS
    Asukai, Y.
    Gunsoy, N. B.
    Koblbauer, I
    Pascoe, K.
    Williams, J.
    Vetrini, D.
    Kay, G.
    Mealing, S.
    Fenwick, E.
    [J]. VALUE IN HEALTH, 2018, 21 : S223 - S223
  • [30] Cost-effectiveness of salmeterol in patients with chronic obstructive pulmonary disease: an economic evaluation
    Jones, PW
    Wilson, K
    Sondhi, S
    [J]. RESPIRATORY MEDICINE, 2003, 97 (01) : 20 - 26
12345